Annual FCF
$1.29 B
+$727.11 M+130.00%
30 June 2024
Summary:
ResMed annual free cash flow is currently $1.29 billion, with the most recent change of +$727.11 million (+130.00%) on 30 June 2024. During the last 3 years, it has risen by +$666.51 million (+107.52%). RMD annual FCF is now at all-time high.RMD Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
$305.93 M
-$107.86 M-26.07%
30 September 2024
Summary:
ResMed quarterly free cash flow is currently $305.93 million, with the most recent change of -$107.86 million (-26.07%) on 30 September 2024. Over the past year, it has increased by +$60.51 million (+24.66%). RMD quarterly FCF is now -26.07% below its all-time high of $413.79 million, reached on 30 June 2024.RMD Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
$1.35 B
+$60.51 M+4.70%
30 September 2024
Summary:
ResMed TTM free cash flow is currently $1.35 billion, with the most recent change of +$60.51 million (+4.70%) on 30 September 2024. Over the past year, it has increased by +$554.49 million (+69.97%). RMD TTM FCF is now at all-time high.RMD TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RMD Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +130.0% | +24.7% | +70.0% |
| 3 y3 years | +107.5% | +413.9% | +239.1% |
| 5 y5 years | +237.0% | +122.3% | +176.7% |
RMD Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +559.3% | -26.1% | +413.9% | at high | +590.3% |
| 5 y | 5 years | at high | +559.3% | -26.1% | +413.9% | at high | +590.3% |
| alltime | all time | at high | >+9999.0% | -26.1% | +413.9% | at high | +5745.8% |
ResMed Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $305.93 M(-26.1%) | $1.35 B(+4.7%) |
| June 2024 | $1.29 B(+130.0%) | $413.79 M(+9.2%) | $1.29 B(+20.1%) |
| Mar 2024 | - | $378.92 M(+52.6%) | $1.07 B(+13.5%) |
| Dec 2023 | - | $248.27 M(+1.2%) | $943.73 M(+19.1%) |
| Sept 2023 | - | $245.42 M(+23.5%) | $792.43 M(+41.7%) |
| June 2023 | $559.30 M(+186.7%) | $198.70 M(-20.9%) | $559.30 M(+37.2%) |
| Mar 2023 | - | $251.34 M(+159.2%) | $407.69 M(+84.0%) |
| Dec 2022 | - | $96.97 M(+689.1%) | $221.63 M(-27.3%) |
| Sept 2022 | - | $12.29 M(-73.9%) | $304.85 M(+56.2%) |
| June 2022 | $195.11 M(-68.5%) | $47.09 M(-27.9%) | $195.11 M(-43.2%) |
| Mar 2022 | - | $65.28 M(-63.8%) | $343.67 M(-22.9%) |
| Dec 2021 | - | $180.19 M(-284.9%) | $445.52 M(+12.2%) |
| Sept 2021 | - | -$97.45 M(-149.8%) | $397.18 M(-35.9%) |
| June 2021 | $619.89 M(-11.0%) | $195.65 M(+17.1%) | $619.89 M(-15.5%) |
| Mar 2021 | - | $167.13 M(+26.8%) | $733.32 M(-5.2%) |
| Dec 2020 | - | $131.84 M(+5.3%) | $773.77 M(+13.1%) |
| Sept 2020 | - | $125.26 M(-59.5%) | $683.96 M(-1.8%) |
| June 2020 | $696.32 M(+82.4%) | $309.08 M(+48.9%) | $696.32 M(+37.9%) |
| Mar 2020 | - | $207.59 M(+393.9%) | $504.78 M(+20.2%) |
| Dec 2019 | - | $42.03 M(-69.5%) | $419.84 M(-13.8%) |
| Sept 2019 | - | $137.62 M(+17.1%) | $486.82 M(+27.5%) |
| June 2019 | $381.71 M(-12.0%) | $117.54 M(-4.2%) | $381.71 M(+2.1%) |
| Mar 2019 | - | $122.65 M(+12.5%) | $373.83 M(-2.9%) |
| Dec 2018 | - | $109.00 M(+235.3%) | $385.18 M(-1.3%) |
| Sept 2018 | - | $32.51 M(-70.4%) | $390.37 M(-10.0%) |
| June 2018 | $433.57 M(+26.6%) | $109.66 M(-18.2%) | $433.57 M(-2.3%) |
| Mar 2018 | - | $134.00 M(+17.3%) | $443.58 M(+23.1%) |
| Dec 2017 | - | $114.20 M(+50.8%) | $360.19 M(+3.2%) |
| Sept 2017 | - | $75.71 M(-36.7%) | $349.08 M(+1.9%) |
| June 2017 | $342.58 M(-28.6%) | $119.67 M(+136.5%) | $342.58 M(-1.9%) |
| Mar 2017 | - | $50.61 M(-50.9%) | $349.06 M(-14.4%) |
| Dec 2016 | - | $103.08 M(+48.9%) | $408.01 M(-8.0%) |
| Sept 2016 | - | $69.21 M(-45.1%) | $443.53 M(-7.6%) |
| June 2016 | $480.10 M(+54.3%) | $126.16 M(+15.1%) | $480.10 M(+9.3%) |
| Mar 2016 | - | $109.56 M(-21.0%) | $439.08 M(+7.7%) |
| Dec 2015 | - | $138.60 M(+31.0%) | $407.57 M(+15.3%) |
| Sept 2015 | - | $105.78 M(+24.3%) | $353.53 M(+13.6%) |
| June 2015 | $311.24 M(+0.4%) | $85.13 M(+9.1%) | $311.24 M(-2.9%) |
| Mar 2015 | - | $78.05 M(-7.7%) | $320.43 M(-0.9%) |
| Dec 2014 | - | $84.56 M(+33.2%) | $323.34 M(+7.2%) |
| Sept 2014 | - | $63.49 M(-32.7%) | $301.61 M(-2.7%) |
| June 2014 | $310.11 M(-6.3%) | $94.33 M(+16.5%) | $310.11 M(-3.5%) |
| Mar 2014 | - | $80.96 M(+28.9%) | $321.35 M(-1.5%) |
| Dec 2013 | - | $62.83 M(-12.7%) | $326.40 M(-3.9%) |
| Sept 2013 | - | $71.99 M(-31.8%) | $339.65 M(+2.6%) |
| June 2013 | $331.04 M(+2.8%) | $105.57 M(+22.7%) | $331.04 M(+7.2%) |
| Mar 2013 | - | $86.01 M(+13.1%) | $308.92 M(+3.9%) |
| Dec 2012 | - | $76.08 M(+20.0%) | $297.33 M(-6.3%) |
| Sept 2012 | - | $63.39 M(-24.0%) | $317.48 M(-1.4%) |
| June 2012 | $322.05 M(+53.2%) | $83.44 M(+12.1%) | $322.05 M(+9.5%) |
| Mar 2012 | - | $74.42 M(-22.7%) | $294.05 M(+3.3%) |
| Dec 2011 | - | $96.23 M(+41.6%) | $284.74 M(+20.8%) |
| Sept 2011 | - | $67.96 M(+22.6%) | $235.76 M(+12.2%) |
| June 2011 | $210.15 M(+66.0%) | $55.44 M(-14.8%) | $210.15 M(+7.2%) |
| Mar 2011 | - | $65.11 M(+37.8%) | $196.04 M(+14.2%) |
| Dec 2010 | - | $47.25 M(+11.6%) | $171.64 M(+42.8%) |
| Sept 2010 | - | $42.35 M(+2.5%) | $120.18 M(-5.0%) |
| June 2010 | $126.57 M | $41.33 M(+1.5%) | $126.57 M(+1.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2010 | - | $40.71 M(-1068.3%) | $124.50 M(+18.7%) |
| Dec 2009 | - | -$4.20 M(-108.6%) | $104.87 M(-22.8%) |
| Sept 2009 | - | $48.73 M(+24.1%) | $135.90 M(+12.7%) |
| June 2009 | $120.61 M(+94.4%) | $39.26 M(+86.2%) | $120.61 M(-3.7%) |
| Mar 2009 | - | $21.08 M(-21.4%) | $125.22 M(+5.7%) |
| Dec 2008 | - | $26.83 M(-19.8%) | $118.51 M(+38.2%) |
| Sept 2008 | - | $33.44 M(-23.8%) | $85.74 M(+38.2%) |
| June 2008 | $62.06 M(+358.0%) | $43.87 M(+205.3%) | $62.06 M(+103.0%) |
| Mar 2008 | - | $14.37 M(-341.8%) | $30.57 M(+47.1%) |
| Dec 2007 | - | -$5.94 M(-160.9%) | $20.78 M(-17.9%) |
| Sept 2007 | - | $9.76 M(-21.1%) | $25.32 M(+86.9%) |
| June 2007 | $13.55 M(-464.1%) | $12.38 M(+169.8%) | $13.55 M(+5.3%) |
| Mar 2007 | - | $4.59 M(-427.5%) | $12.87 M(-48.8%) |
| Dec 2006 | - | -$1.40 M(-30.4%) | $25.14 M(+40.4%) |
| Sept 2006 | - | -$2.01 M(-117.2%) | $17.90 M(-581.0%) |
| June 2006 | -$3.72 M(-111.9%) | $11.70 M(-30.6%) | -$3.72 M(-51.5%) |
| Mar 2006 | - | $16.86 M(-295.1%) | -$7.67 M(-67.8%) |
| Dec 2005 | - | -$8.64 M(-63.4%) | -$23.86 M(+1593.2%) |
| Sept 2005 | - | -$23.63 M(-405.1%) | -$1.41 M(-104.5%) |
| June 2005 | $31.39 M(+62.7%) | $7.75 M(+1054.2%) | $31.39 M(-12.1%) |
| Mar 2005 | - | $671.00 K(-95.1%) | $35.73 M(-17.5%) |
| Dec 2004 | - | $13.81 M(+50.7%) | $43.30 M(+60.9%) |
| Sept 2004 | - | $9.16 M(-24.2%) | $26.92 M(+39.5%) |
| June 2004 | $19.30 M(-42.7%) | $12.09 M(+46.6%) | $19.30 M(-4.7%) |
| Mar 2004 | - | $8.25 M(-419.8%) | $20.25 M(-12.2%) |
| Dec 2003 | - | -$2.58 M(-267.4%) | $23.06 M(-27.8%) |
| Sept 2003 | - | $1.54 M(-88.2%) | $31.94 M(-5.1%) |
| June 2003 | $33.65 M(+351.4%) | $13.04 M(+17.9%) | $33.65 M(+101.5%) |
| Mar 2003 | - | $11.06 M(+75.6%) | $16.70 M(+54.0%) |
| Dec 2002 | - | $6.30 M(+93.5%) | $10.84 M(+407.7%) |
| Sept 2002 | - | $3.25 M(-183.2%) | $2.13 M(-71.4%) |
| June 2002 | $7.46 M(+261.7%) | -$3.91 M(-175.2%) | $7.46 M(-59.1%) |
| Mar 2002 | - | $5.20 M(-315.9%) | $18.23 M(-1.6%) |
| Dec 2001 | - | -$2.41 M(-128.1%) | $18.53 M(-21.4%) |
| Sept 2001 | - | $8.57 M(+24.9%) | $23.57 M(+1043.8%) |
| June 2001 | $2.06 M(-49.8%) | $6.86 M(+24.8%) | $2.06 M(-136.6%) |
| Mar 2001 | - | $5.50 M(+108.4%) | -$5.64 M(-25.7%) |
| Dec 2000 | - | $2.64 M(-120.4%) | -$7.59 M(-25.1%) |
| Sept 2000 | - | -$12.94 M(+1447.6%) | -$10.13 M(-346.7%) |
| June 2000 | $4.11 M(-195.5%) | -$836.00 K(-123.6%) | $4.11 M(-3.2%) |
| Mar 2000 | - | $3.54 M(+3443.0%) | $4.24 M(-1514.3%) |
| Dec 1999 | - | $100.00 K(-92.3%) | -$300.00 K(-87.5%) |
| Sept 1999 | - | $1.30 M(-285.7%) | -$2.40 M(-44.2%) |
| June 1999 | -$4.30 M(-14.0%) | -$700.00 K(-30.0%) | -$4.30 M(+30.3%) |
| Mar 1999 | - | -$1.00 M(-50.0%) | -$3.30 M(+13.8%) |
| Dec 1998 | - | -$2.00 M(+233.3%) | -$2.90 M(-48.2%) |
| Sept 1998 | - | -$600.00 K(-300.0%) | -$5.60 M(+12.0%) |
| June 1998 | -$5.00 M(-190.9%) | $300.00 K(-150.0%) | -$5.00 M(+28.2%) |
| Mar 1998 | - | -$600.00 K(-87.2%) | -$3.90 M(+62.5%) |
| Dec 1997 | - | -$4.70 M(<-9900.0%) | -$2.40 M(-154.5%) |
| Sept 1997 | - | $0.00(-100.0%) | $4.40 M(-20.0%) |
| June 1997 | $5.50 M(+175.0%) | $1.40 M(+55.6%) | $5.50 M(+34.1%) |
| Mar 1997 | - | $900.00 K(-57.1%) | $4.10 M(+28.1%) |
| Dec 1996 | - | $2.10 M(+90.9%) | $3.20 M(+190.9%) |
| Sept 1996 | - | $1.10 M | $1.10 M |
| June 1996 | $2.00 M(-281.8%) | - | - |
| June 1995 | -$1.10 M(-184.6%) | - | - |
| June 1994 | $1.30 M(+85.7%) | - | - |
| June 1993 | $700.00 K | - | - |
FAQ
- What is ResMed annual free cash flow?
- What is the all time high annual FCF for ResMed?
- What is ResMed annual FCF year-on-year change?
- What is ResMed quarterly free cash flow?
- What is the all time high quarterly FCF for ResMed?
- What is ResMed quarterly FCF year-on-year change?
- What is ResMed TTM free cash flow?
- What is the all time high TTM FCF for ResMed?
- What is ResMed TTM FCF year-on-year change?
What is ResMed annual free cash flow?
The current annual FCF of RMD is $1.29 B
What is the all time high annual FCF for ResMed?
ResMed all-time high annual free cash flow is $1.29 B
What is ResMed annual FCF year-on-year change?
Over the past year, RMD annual free cash flow has changed by +$727.11 M (+130.00%)
What is ResMed quarterly free cash flow?
The current quarterly FCF of RMD is $305.93 M
What is the all time high quarterly FCF for ResMed?
ResMed all-time high quarterly free cash flow is $413.79 M
What is ResMed quarterly FCF year-on-year change?
Over the past year, RMD quarterly free cash flow has changed by +$60.51 M (+24.66%)
What is ResMed TTM free cash flow?
The current TTM FCF of RMD is $1.35 B
What is the all time high TTM FCF for ResMed?
ResMed all-time high TTM free cash flow is $1.35 B
What is ResMed TTM FCF year-on-year change?
Over the past year, RMD TTM free cash flow has changed by +$554.49 M (+69.97%)